Daniel Auclair, Ph.D., Chief Scientific Officer, The Multiple Myeloma Research Foundation speaks about MMRF CureCloud – First At-home Genomic Testing Program/Multiple Myeloma.
Link to MMRF CureCloud:
https://mmrfcurecloud.org/
In the first at-home genetic testing program, the MMRF CureCloud will integrate huge quantities of health data from thousands of multiple myeloma patients. It is the world’s first, largest, and most comprehensive myeloma database. It is also an important resource for scientists, clinicians, and patients who are striving to create cures, enhance patient quality of life, and identify therapies.
Myeloma is not only an uncommon illness, but it also has a wide range of symptoms. Our groundbreaking MMRF CoMMpassSM Study, which used the world’s biggest genetic dataset on cancer, revealed that there are several subtypes of multiple myeloma. The MMRF CureCloud is the next stage in finding therapies for all patients, regardless of subtype. It will benefit patients and their clinicians in making better educated, data-driven decisions by assisting researchers in discovering novel targets for myeloma and forming hypotheses for clinical trials.
However, the MMRF CureCloud is only as good as the data it contains, which is why we need patients to participate.